Skip to main content
. 2019 Dec 2;14:9453–9467. doi: 10.2147/IJN.S224579

Scheme 1.

Scheme 1

Schematic representation of the nanoparticles in ovarian cancer tissue microenvironment. (A) Preparation of drug-loaded nanoparticles; (B) In vivo treatment process.